346 related articles for article (PubMed ID: 21719443)
1. Genetic activation of Nrf2 signaling is sufficient to ameliorate neurodegenerative phenotypes in a Drosophila model of Parkinson's disease.
Barone MC; Sykiotis GP; Bohmann D
Dis Model Mech; 2011 Sep; 4(5):701-7. PubMed ID: 21719443
[TBL] [Abstract][Full Text] [Related]
2. Activation of Nrf2 in Astrocytes Suppressed PD-Like Phenotypes via Antioxidant and Autophagy Pathways in Rat and Drosophila Models.
Guo Q; Wang B; Wang X; Smith WW; Zhu Y; Liu Z
Cells; 2021 Jul; 10(8):. PubMed ID: 34440619
[TBL] [Abstract][Full Text] [Related]
3. Glial Nrf2 signaling mediates the neuroprotection exerted by
Lin YE; Lin CH; Ho EP; Ke YC; Petridi S; Elliott CJ; Sheen LY; Chien CT
Elife; 2021 Nov; 10():. PubMed ID: 34779396
[TBL] [Abstract][Full Text] [Related]
4. Nrf2 inducer and cncC overexpression attenuates neurodegeneration due to α-synuclein in Drosophila.
Wang B; Liu Q; Shan H; Xia C; Liu Z
Biochem Cell Biol; 2015 Aug; 93(4):351-8. PubMed ID: 26008822
[TBL] [Abstract][Full Text] [Related]
5. Activation of p62-Keap1-Nrf2 Pathway Protects 6-Hydroxydopamine-Induced Ferroptosis in Dopaminergic Cells.
Sun Y; He L; Wang T; Hua W; Qin H; Wang J; Wang L; Gu W; Li T; Li N; Liu X; Chen F; Tang L
Mol Neurobiol; 2020 Nov; 57(11):4628-4641. PubMed ID: 32770451
[TBL] [Abstract][Full Text] [Related]
6. Gintonin Mitigates MPTP-Induced Loss of Nigrostriatal Dopaminergic Neurons and Accumulation of α-Synuclein via the Nrf2/HO-1 Pathway.
Jo MG; Ikram M; Jo MH; Yoo L; Chung KC; Nah SY; Hwang H; Rhim H; Kim MO
Mol Neurobiol; 2019 Jan; 56(1):39-55. PubMed ID: 29675576
[TBL] [Abstract][Full Text] [Related]
7. The principal molecular mechanisms behind the activation of Keap1/Nrf2/ARE pathway leading to neuroprotective action in Parkinson's disease.
Chakkittukandiyil A; Sajini DV; Karuppaiah A; Selvaraj D
Neurochem Int; 2022 Jun; 156():105325. PubMed ID: 35278519
[TBL] [Abstract][Full Text] [Related]
8. The Bcl-2 homologue Buffy rescues α-synuclein-induced Parkinson disease-like phenotypes in Drosophila.
M'Angale PG; Staveley BE
BMC Neurosci; 2016 May; 17(1):24. PubMed ID: 27192974
[TBL] [Abstract][Full Text] [Related]
9. Axonal pathology in hPSC-based models of Parkinson's disease results from loss of Nrf2 transcriptional activity at the Map1b gene locus.
Czaniecki C; Ryan T; Stykel MG; Drolet J; Heide J; Hallam R; Wood S; Coackley C; Sherriff K; Bailey CDC; Ryan SD
Proc Natl Acad Sci U S A; 2019 Jul; 116(28):14280-14289. PubMed ID: 31235589
[TBL] [Abstract][Full Text] [Related]
10. Safranal prevents rotenone-induced oxidative stress and apoptosis in an in vitro model of Parkinson's disease through regulating Keap1/Nrf2 signaling pathway.
Pan PK; Qiao LY; Wen XN
Cell Mol Biol (Noisy-le-grand); 2016 Dec; 62(14):11-17. PubMed ID: 28145852
[TBL] [Abstract][Full Text] [Related]
11. Activation of the Nrf2-ARE pathway by siRNA knockdown of Keap1 reduces oxidative stress and provides partial protection from MPTP-mediated neurotoxicity.
Williamson TP; Johnson DA; Johnson JA
Neurotoxicology; 2012 Jun; 33(3):272-9. PubMed ID: 22342405
[TBL] [Abstract][Full Text] [Related]
12. Tissue-specific Nrf2 signaling protects against methylmercury toxicity in Drosophila neuromuscular development.
Gunderson JT; Peppriell AE; Vorojeikina D; Rand MD
Arch Toxicol; 2020 Dec; 94(12):4007-4022. PubMed ID: 32816092
[TBL] [Abstract][Full Text] [Related]
13. Bruceine D elevates Nrf2 activation to restrain Parkinson's disease in mice through suppressing oxidative stress and inflammatory response.
Yang Y; Kong F; Ding Q; Cai Y; Hao Y; Tang B
Biochem Biophys Res Commun; 2020 Jun; 526(4):1013-1020. PubMed ID: 32321640
[TBL] [Abstract][Full Text] [Related]
14. Isocitrate protects DJ-1 null dopaminergic cells from oxidative stress through NADP+-dependent isocitrate dehydrogenase (IDH).
Yang J; Kim MJ; Yoon W; Kim EY; Kim H; Lee Y; Min B; Kang KS; Son JH; Park HT; Chung J; Koh H
PLoS Genet; 2017 Aug; 13(8):e1006975. PubMed ID: 28827794
[TBL] [Abstract][Full Text] [Related]
15. Nrf2-Keap1 antioxidant defense and cell survival signaling are upregulated by 17β-estradiol in homocysteine-treated dopaminergic SH-SY5Y cells.
Chen CS; Tseng YT; Hsu YY; Lo YC
Neuroendocrinology; 2013; 97(3):232-41. PubMed ID: 22948038
[TBL] [Abstract][Full Text] [Related]
16. Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer's disease.
Kerr F; Sofola-Adesakin O; Ivanov DK; Gatliff J; Gomez Perez-Nievas B; Bertrand HC; Martinez P; Callard R; Snoeren I; Cochemé HM; Adcott J; Khericha M; Castillo-Quan JI; Wells G; Noble W; Thornton J; Partridge L
PLoS Genet; 2017 Mar; 13(3):e1006593. PubMed ID: 28253260
[TBL] [Abstract][Full Text] [Related]
17. Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like Disease.
Ahuja M; Ammal Kaidery N; Yang L; Calingasan N; Smirnova N; Gaisin A; Gaisina IN; Gazaryan I; Hushpulian DM; Kaddour-Djebbar I; Bollag WB; Morgan JC; Ratan RR; Starkov AA; Beal MF; Thomas B
J Neurosci; 2016 Jun; 36(23):6332-51. PubMed ID: 27277809
[TBL] [Abstract][Full Text] [Related]
18. Nrf2 activator via interference of Nrf2-Keap1 interaction has antioxidant and anti-inflammatory properties in Parkinson's disease animal model.
Kim S; Indu Viswanath AN; Park JH; Lee HE; Park AY; Choi JW; Kim HJ; Londhe AM; Jang BK; Lee J; Hwang H; Lim SM; Pae AN; Park KD
Neuropharmacology; 2020 May; 167():107989. PubMed ID: 32032607
[TBL] [Abstract][Full Text] [Related]
19. Loss of porin function in dopaminergic neurons of Drosophila is suppressed by Buffy.
M'Angale PG; Staveley BE
J Biomed Sci; 2016 Nov; 23(1):84. PubMed ID: 27881168
[TBL] [Abstract][Full Text] [Related]
20. Lovastatin protects neurite degeneration in LRRK2-G2019S parkinsonism through activating the Akt/Nrf pathway and inhibiting GSK3β activity.
Lin CH; Lin HI; Chen ML; Lai TT; Cao LP; Farrer MJ; Wu RM; Chien CT
Hum Mol Genet; 2016 May; 25(10):1965-1978. PubMed ID: 26931464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
